A detailed history of Pnc Financial Services Group, Inc. transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,000 shares of RANI stock, worth $2,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$2,920
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$3.13 - $7.85 $22,273 - $55,860
-7,116 Reduced 78.06%
2,000 $7,000
Q4 2023

Feb 09, 2024

BUY
$1.85 - $3.67 $3,145 - $6,239
1,700 Added 22.92%
9,116 $30,000
Q2 2022

Aug 12, 2022

BUY
$8.0 - $14.25 $56,928 - $101,403
7,116 Added 2372.0%
7,416 $76,000
Q4 2021

Feb 11, 2022

BUY
$16.09 - $35.0 $4,827 - $10,500
300 New
300 $4,000

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $35.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.